Abstract:BACKGROUND:The two-component NS2B-NS3 proteases of West Nile and dengue viruses are essential for viral replication and established targets for drug development. In all crystal structures of the proteases to date, the NS2B cofactor is located far from the substrate binding site (open conformation) in the absence of inhibitor and lining the substrate binding site (closed conformation) in the presence of an inhibitor.METHODS:In this work, nuclear magnetic resonance (NMR) spectroscopy of isotope and spin-labeled samples of the West Nile virus protease was used to investigate the occurrence of equilibria between open and closed conformations in solution.FINDINGS:In solution, the closed form of the West Nile virus protease is the predominant conformation irrespective of the presence or absence of inhibitors. Nonetheless, dissociation of the C-terminal part of the NS2B cofactor from the NS3 protease (open conformation) occurs in both the presence and the absence of inhibitors. Low-molecular-weight inhibitors can shift the conformational exchange equilibria so that over 90% of the West Nile virus protease molecules assume the closed conformation. The West Nile virus protease differs from the dengue virus protease, where the open conformation is the predominant form in the absence of inhibitors.CONCLUSION:Partial dissociation of NS2B from NS3 has implications for the way in which the NS3 protease can be positioned with respect to the host cell membrane when NS2B is membrane associated via N- and C-terminal segments present in the polyprotein. In the case of the West Nile virus protease, discovery of low-molecular-weight inhibitors that act by breaking the association of the NS2B cofactor with the NS3 protease is impeded by the natural affinity of the cofactor to the NS3 protease. The same strategy can be more successful in the case of the dengue virus NS2B-NS3 protease.

Structural Basis for the Activation of Flaviviral NS3 Proteases from Dengue and West Nile Virus

Crystal structures of full length DENV4 NS2B-NS3 reveal the dynamic interaction between NS2B and NS3

Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design.

NMR Analysis of the Dynamic Exchange of the NS2B Cofactor Between Open and Closed Conformations of the West Nile Virus NS2B-NS3 Protease.

Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase.

Cleavage targets and the <scp>D</scp>-arginine-based inhibitors of the West Nile virus NS3 processing proteinase

Structure of the NS2B-NS3 protease from Zika virus after self-cleavage

Crystal structure of unlinked NS2B-NS3 protease from Zika virus.

Allostery in the dengue virus NS3 helicase: Insights into the NTPase cycle from molecular simulations

Structure-Based Macrocyclization of Substrate Analogue NS2B-NS3 Protease Inhibitors of Zika, West Nile and Dengue viruses

Structural characterization of the linked NS2B-NS3 protease of Zika virus.

Novel insights into the function of an N-terminal region of DENV2 NS4B for the optimal helicase activity of NS3

Structural Dynamics of Zika Virus NS2B-NS3 Protease Binding to Dipeptide Inhibitors.

Functional Determinants of NS2B for Activation of Japanese Encephalitis Virus NS3 Protease.

Structural and Functional Studies of Chikungunya Virus nsP2

Structure and functionality in flavivirus NS-proteins: perspectives for drug design

Deciphering the interaction surface between the West Nile virus NS3 and NS5 proteins

Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics.

NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease.

Yellow Fever Virus Ns3 Protease: Peptide-Inhibition Studies

Peptide Inhibitors of West Nile NS3 Protease: SAR Study of Tetrapeptide Aldehyde Inhibitors.